Quick search
In Drug search, users can search candidate drugs/compounds that associate with CS.
Result
This table shows chemicals/drugs, their mechanism of action(MOA) and association with CS.
| Chemical | Cancer | MOA | Association | ||
|---|---|---|---|---|---|
| navitoclax | STAD | BCL inhibitor | negatively | ||
| neurodazine | STAD | Neurogenesis of non-pluripotent C2C12 myoblast inducer | negatively | ||
| NF-449 | STAD | Purinergic receptor antagonist | negatively | ||
| nifekalant | STAD | Potassium channel blocker | negatively | ||
| orantinib | STAD | FGFR inhibitor | negatively | ||
| palonosetron | STAD | Serotonin receptor antagonist | negatively | ||
| piceid | STAD | Glucosidase inhibitor | negatively | ||
| PKCbeta-inhibitor | STAD | PKC inhibitor | negatively | ||
| prima-1-met | STAD | thioredoxin inhibitor | negatively | ||
| PRL-3-inhibitor-I | STAD | Tyrosine phosphatase inhibitor | negatively | ||
| prostaglandin-a1 | STAD | HSP inducer | negatively | ||
| PT-630 | STAD | Dipeptidyl peptidase inhibitor | negatively | ||
| quinine | STAD | Hemozoin biocrystallization inhibitor | negatively | ||
| QX-314 | STAD | Sodium channel blocker | negatively | ||
| RHO-kinase-inhibitor-III[rockout] | STAD | Rho associated kinase inhibitor | negatively | ||
| rilmenidine | STAD | Imidazoline receptor agonist | negatively | ||
| RITA | STAD | MDM inhibitor | negatively | ||
| rivaroxaban | STAD | Coagulation inhibitor | negatively | ||
| ruxolitinib | STAD | JAK inhibitor | negatively | ||
| SB-216763 | STAD | Glycogen synthase kinase inhibitor | negatively | ||